ArticleBMJ open2017
Diagnostic performance of an automatic blood pressure measurement device, Microlife WatchBP Home A, for atrial fibrillation screening in a real-world primary care setting.
Article in BMJ open, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
31 citing papers in PubMed, 1 synthesis or guideline pooled it, 58 citations in OpenAlex.
- Sensitivity and specificity of automated blood pressure devices to detect atrial fibrillation: A systematic review and meta-analysis of diagnostic accuracy.Frontiers in cardiovascular medicine · 2022Pooled it
- Pharmacist interventions to improve blood pressure control in primary care: a cluster randomised trial.International journal of clinical pharmacy · 2023Trial
- Trial
- Systematic screening for atrial fibrillation with non-invasive devices: a systematic review and meta-analysis.The Lancet regional health. Europe · 2025Article
- Evaluation of the performance of a machine learning based atrial fibrillation screening algorithm using an oscillometric blood pressure monitor.Scientific reports · 2024Article
- Screening for atrial fibrillation in care homes using pulse palpation and the AliveCor Kardia Mobile® device: a comparative cross-sectional pilot study.International journal of clinical pharmacy · 2024Article
- Standardized protocol of blood pressure measurement and quality control program for the Korea National Health and Nutrition Examination Survey.Clinical hypertension · 2023Review
- Regional implementation of atrial fibrillation screening: benefits and pitfalls.European heart journal. Digital health · 2022Article
- DoesMedicina (Kaunas, Lithuania) · 2022Article
- Prediction of atrial fibrillation using a home blood pressure monitor with a high-resolution system.Open heart · 2022Article
- Screening, Diagnosis and Management of Atrial Fibrillation in Cancer Patients: Current Evidence and Future Perspectives.Arquivos brasileiros de cardiologia · 2022Review
- Improving Knowledge and Early Detection of Atrial Fibrillation through a Community-Based Opportunistic Screening Program: What's Your Beat?International journal of environmental research and public health · 2022Article
- 2021 Asia Pacific Heart Rhythm Society (APHRS) practice guidance on atrial fibrillation screening.Journal of arrhythmia · 2022Article
- Screening for atrial fibrillation during automated blood pressure measurement among patients admitted to internal medicine ward.Internal and emergency medicine · 2021Article
- HRS White Paper on Clinical Utilization of Digital Health Technology.Cardiovascular digital health journal · 2021Article
- Letter to the Editor on "Atrial fibrillation prevalence and risk profile from novel community-based screening in Thailand: A prospective multi-centre study".International journal of cardiology. Heart & vasculature · 2021Article
- Response to letter to the editor regarding: "Atrial fibrillation prevalence and risk profile from novel community-based screening in Thailand: A prospective multi-centre study".International journal of cardiology. Heart & vasculature · 2021Article
- New Technologies for Detection and Management of Atrial Fibrillation.Journal of the Saudi Heart Association · 2021Review
- Experience in screening for atrial fibrillation and monitoring arrhythmia using a single-lead ECG stick.Herzschrittmachertherapie & Elektrophysiologie · 2020Review
- [Cardiac rhythm monitoring : New tools on the horizon].Herzschrittmachertherapie & Elektrophysiologie · 2020Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors at 2 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo evaluate the diagnostic performance of a UK National Institute for Health and Care Excellence-recommended automatic oscillometric blood pressure (BP) measurement device incorporated with an atrial fibrillation (AF) detection algorithm (Microlife WatchBP Home A) for real-world AF screening in a primary healthcare setting.
settingPrimary healthcare setting in Hong Kong.
interventionsThis was a prospective AF screening study carried out between 1 September 2014 and 14 January 2015. The Microlife device was evaluated for AF detection and compared with a reference standard of lead-I ECG. PRIMARY OUTCOME MEASURES: Diagnostic performance of Microlife for AF detection.
results5969 patients (mean age: 67.2±11.0 years; 53.9% female) were recruited. The mean CHA
conclusionsIn the primary care setting, Microlife WatchBP Home was an effective means to screen for AF, with a reasonable sensitivity of 80.6% and a high negative predictive value of 99.8%, in addition to its routine function of BP measurement. In a younger patient population aged <65 years with a lower prevalence of AF, Microlife WatchBP Home A demonstrated a similar diagnostic accuracy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.